Second-line treatment for advanced NSCLC without actionable mutations: is immunotherapy the ‘panacea’ for all patients?
Sign Up to like & getrecommendations! Published in 2018 at "BMC Medicine"
DOI: 10.1186/s12916-018-1011-0
Abstract: The therapeutic approach for the second-line treatment of patients with advanced non-small cell lung cancer (NSCLC) without actionable mutations has been revolutionized by the recent approval of new effective drugs with various mechanisms of action,… read more here.
Keywords: nsclc without; medicine; line; advanced nsclc ... See more keywords
Management of patients with advanced NSCLC without actionable mutations: A simulation-based assessment of medical oncologists.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e21041
Abstract: e21041Background: There have been many changes to the advanced NSCLC (aNSCLC) treatment algorithm, challenging oncologists to assimilate evidence and guidelines into practice. Methods: A CME virtua... read more here.
Keywords: nsclc without; actionable mutations; without actionable; advanced nsclc ... See more keywords